Apreo Health

Apreo Health

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.2M

Overview

Apreo Health is a private, early-stage digital health company targeting the significant unmet needs in lung disease management. Operating in a pre-revenue, investigational stage, the company is developing a medical device platform currently limited to clinical investigations under U.S. regulatory law. Its mission centers on creating patient-centric, transformative solutions to improve respiratory health outcomes, positioning it in the high-growth digital therapeutics and remote monitoring landscape for chronic pulmonary conditions.

PulmonologyRespiratory Diseases

Technology Platform

Investigational digital health platform for lung disease, likely involving remote monitoring, digital biomarkers, and therapeutic software interventions.

Funding History

1
Total raised:$3.2M
Seed$3.2M

Opportunities

The large and growing global burden of chronic respiratory diseases presents a multi-billion dollar addressable market.
The accelerated adoption of telehealth and remote patient monitoring creates a receptive environment for digital solutions that can reduce hospitalizations and improve quality of life.

Risk Factors

The company faces significant regulatory risk in obtaining FDA clearance for its novel investigational device.
As a pre-revenue startup, it is also highly dependent on securing additional funding to complete costly clinical trials and achieve commercialization.

Competitive Landscape

The digital health space for respiratory care is competitive, with numerous startups and established medtech companies developing connected inhalers, remote monitoring platforms, and digital therapeutics. Success will require demonstrating superior clinical outcomes, seamless integration, and clear economic value.